Calreticulin is a Critical Cell Survival Factor in Malignant Neoplasms-Reference-Cited by-同舟云学术

Calreticulin is a Critical Cell Survival Factor in Malignant Neoplasms

Published:2019-09-30 Issue:9 Volume:17 Page:e3000402
ISSN:1545-7885
Container-title:PLOS Biology
language:en
Short-container-title:PLoS Biol

Author:

Han Arum,Li Chen,Zahed Tara,Wong Michael^ORCID,Smith Ian,Hoedel Karl^ORCID,Green Douglas,Boiko Alexander D.^ORCID

Funder

UCI Health Melanoma Center

National Institute of Health

American Cancer Society

UCI SCRC

Publisher

Public Library of Science (PLoS)

Subject

General Agricultural and Biological Sciences,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Reference59 articles.

1. Definition of the lectin-like properties of the molecular chaperone, calreticulin, and demonstration of its copurification with endomannosidase from rat liver Golgi;RG Spiro;J Biol Chem,1996

2. Calreticulin, a multi-process calcium-buffering chaperone of the endoplasmic reticulum;M Michalak;Biochem J,2009

3. Calreticulin and cancer;M Zamanian;Pathol Oncol Res,2013

4. Calreticulin: non-endoplasmic reticulum functions in physiology and disease;LI Gold;FASEB J,2010

5. Calreticulin promotes cell motility and enhances resistance to anoikis through STAT3-CTTN-Akt pathway in esophageal squamous cell carcinoma;XL Du;Oncogene,2009

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Prognostic Value and Potential Immune Mechanisms of lncRNAs Related to Immunogenic Cell Death in Papillary Thyroid Carcinoma;Journal of Inflammation Research;2024-03

2. DNA polymerase beta connects tumorigenicity with the circadian clock in liver cancer through the epigenetic demethylation of Per1;Cell Death & Disease;2024-01-20

3. Autoimmune inflammatory myopathy biomarkers;Clinica Chimica Acta;2024-01

4. ARL-17477 is a dual inhibitor of NOS1 and the autophagic-lysosomal system that prevents tumor growth in vitro and in vivo;Scientific Reports;2023-07-04

5. Low-intensity focused ultrasound targeted microbubble destruction reduces tumor blood supply and sensitizes anti-PD-L1 immunotherapy;Frontiers in Bioengineering and Biotechnology;2023-04-17